New and Exciting Distribution Agreement Between SLS and Roche
News Feb 11, 2013
In order to better serve customers in the transfection market, Roche has decided to enter into an agreement with Scientific Laboratory Supplies Limited (SLS Ltd.) for the distribution of the Roche Applied Science X-tremeGENE transfection reagents including the X-tremeGENE 9 and X-tremeGENE HP.
SLS is a leading supplier of scientific equipment, chemicals and consumables and has a major presence nationally.
Its broad network of representatives will be able to visit Roche customers regularly about X-tremeGENE products, providing a higher level of service pre and post sales than we are currently able.
The new arrangement reflects Roche’s commitment to delivering first class support to customers whom, we believe, will see immediate benefits as an outcome.
Single-stranded Origami Technology Drives Drug Delivery Systems and Pharmaceutical Nanofactories ForwardNews
First nanotechnological approach enables the design and replication of complex single-stranded DNA and RNA origami with potential for drug delivery and nanofabrication.READ MORE
Cracking the Code of Coenzyme Q BiosynthesisNews
Coenzyme Q is a vital cog in the body’s energy-producing machinery, a kind of chemical gateway in the conversion of food into cellular fuel. Researchers are developing new tools to shed light on CoQ function, primarily by finding and defining proteins that have a direct link to the chemical. This includes the development of a new multi-omic strategy to identify the global function of an RNA-binding protein that has long been associated with mitochondria and its role in CoQ biosynthesis.READ MORE
First Successful Gene Therapy Trial Reported for People with Hemophilia ANews
Patients with hemophilia A who received a single infusion of an investigational gene therapy showed improved levels of the essential blood clotting protein FVIII, with 11 of 13 achieving normal or near-normal FVIII levels.READ MORE